| Financial Year |
March 31 2023 |
| Monetary Funds |
1,842,251,705.72 |
| Held-for-trading Financial Assets |
612,877,366.83 |
| Notes Receivable |
125,460,783.71 |
| Accounts Receivable |
572,029,095.06 |
| Advances to Suppliers |
165,095,825.47 |
| Other Receivables |
46,379,646.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
18,563,298.41 |
| Inventories |
2,127,737,177.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,379,191.18 |
| Total Current Assets |
5,611,629,901.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
207,088,336.75 |
| Investment Properties |
20,235,593.51 |
| Fixed Assetes |
5,684,227,975.81 |
| Under-construction Projects |
302,975,733.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
350,250,579.72 |
| R&D expenses |
-- |
| Goodwill |
20,563,803.29 |
| Long-Term Deferred and Prepaid Expenses |
2,690,507.96 |
| Deferred Income Tax Assets |
147,716,612.66 |
| Other Non-Current Assets |
150,745,751.30 |
| Sub-Total of Non-Current Assets |
7,695,155,562.27 |
| Total Assets |
13,306,785,463.97 |
| Short-Term Loans |
614,720,431.89 |
| Trading Financial liabilities |
505,616.88 |
| Notes Payable |
42,600,000.00 |
| Accounts Payable |
172,652,499.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
230,812,553.38 |
| Taxes Payable |
12,400,763.91 |
| Interest Payable |
-- |
| Dividend Payable |
441,113.64 |
| Other payables |
90,193,389.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
407,158,854.12 |
| Other Current Liabilities |
50,750,046.85 |
| Sub-Total of Current Liabilities |
1,788,592,441.29 |
| Long-term Loans |
116,634,001.20 |
| Bonds Payable |
1,450,861,846.79 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
156,141,460.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,034,451,395.84 |
| Total Liabilities |
3,823,043,837.13 |
| Paid-In Capital(Or Share Stock) |
887,633,267.00 |
| Capital Surplus |
402,648,341.16 |
| Surplus Reserve |
1,215,124,336.54 |
| LESS:Treasury Stock |
154,396,198.73 |
| Undistributed Profits |
6,586,669,881.40 |
| Minority Stockholder's Interest |
389,484,464.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,094,257,162.23 |
| Owner's Equity（Stockholder's Equity） |
9,483,741,626.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,306,785,463.97 |
